Aarti Drugs Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Sep ' 24	Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21

Sales

1,036.16

1,169.17

1,176.03

1,234.69

1,016.48

Operating profit

113.76

137.33

124.91

174.78

143.40

Interest

14.63

15.32

15.06

10.84

9.22

Gross profit

99.62

123.40

110.18

166.18

136.71

EPS (Rs)

6.28

8.06

6.80

11.75

9.30

Other income

0.49

1.39

0.33

2.24

2.53

Stock adjustment

13.50

-15.90

-75.06

-25.77

-52.17

Raw material

652.61

790.99

865.59

824.67

700.12

Power and fuel

-

-

-

-

-

Employee expenses

40.81

40.70

34.74

35.67

33.65

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

215.48

216.05

225.85

225.34

191.48

Provisions made

-

-

-

-

-

Depreciation

23.57

23.53

23.75

23.83

23.56

Taxation

18.75

25.75

23.50

33.50

27.00

Net profit / loss

57.30

74.12

62.93

108.85

86.15

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

91.27

91.94

92.60

92.60

92.60

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

10.98

11.75

10.62

14.16

14.11

GPM (%)

9.61

10.54

9.37

13.43

13.42

NPM (%)

5.53

6.33

5.35

8.80

8.45